Trial Profile
Effectiveness of Onabotulinumtoxin A on Reduction of Rest Tremor in Parkinson's Disease: a Pilot Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 26 Aug 2019 Status changed from active, no longer recruiting to completed.
- 18 Feb 2019 Status changed from recruiting to active, no longer recruiting.
- 09 Jan 2019 Planned End Date changed from 1 Mar 2019 to 1 Aug 2019.